DLC & DPAC welcome Medicare news on lower insulin costs
DLC and the Diabetes Patient Advocacy Coalition (DPAC) issued a joint statement in response to CMS’s May 26, 2020, announcement about the Part D Senior Savings Model. Beginning in the 2021 plan year, 3.3 million Medicare beneficiaries with diabetes will see lower, more predictable insulin costs in 1,750 plans that will cap patient cost sharing at $35 for a month’s supply of lifesaving insulin.
This announcement marks a significant step forward for insulin access and affordability. It underscores the combined commitment required to address gaps in our nation’s health care system – advocates, manufacturers, employers and other health plan sponsors, insurers, pharmacy benefit managers, health care providers and policymakers.
Click here to read the full statement.
The DLC in Action
Learn about our commitment to important topics, including: